Cargando…
COVID-19 and liver disease: Are we missing something?
Since the coronavirus disease 2019 (COVID-19) has hit the world as a pandemic, researchers all over the world have worked on its diagnostics, prognosticating factors, etc. The present study showed liver enzymes, especially aspartate aminotransferase (AST) levels, to be high in non-survivors with rai...
Autor principal: | Gupta, Tarana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891679/ https://www.ncbi.nlm.nih.gov/pubmed/35317182 http://dx.doi.org/10.4254/wjh.v14.i2.479 |
Ejemplares similares
-
No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore
por: Gao, Hui, et al.
Publicado: (2022) -
Can we still do something-and what? - for a seemingly missing syndrome?: “Yes we can”
por: Piumelli, Raffaele, et al.
Publicado: (2019) -
Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19–Negative Patients?
por: D’Amario, Domenico, et al.
Publicado: (2020) -
Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
por: Bhatt, Ankeet S., et al.
Publicado: (2020) -
Are We Missing Out on Something?
por: Kapoor, Astha Koolwal, et al.
Publicado: (2018)